Skip to main content
Glama

Ted Eu

by io.github.pipeworx-io

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed1 schema field changed
    • changedInput schema / properties / value / description
      Previous value: -"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\")."New value: +"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed (\"NEW YORK ST DORM AUTH\"), never the question's full noun phrase (\"NEW YORK ST DORM AUTH revenue bonds\"): the FIGI lookup matches instrument names, so trailing security-class words match nothing."
  2. First observed

TDQS

A4.4/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already mark it read-only and idempotent; the description adds materially more: LEI/FIGI enrichment degrades gracefully, ambiguous names return `figi_candidates` rather than an assertion, unresolvable identifiers are reported under `unresolved` rather than omitted, and each call cascades through several endpoints. These are behavioral traits an agent could not infer from the schema or annotations.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness3/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is front-loaded with examples and the 'Use FIRST' directive, but the company type block is a single long run-on with nested parentheticals and semicolons, making it harder to scan. Every clause carries information, but the structure sacrifices readability.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness4/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

For a tool with no output schema, the description does a good job of stating what each entity type returns (CIK+ticker+LEI+FIGI for companies, RxCUI+ingredient+brand for drugs), including the unresolved/candidates fields and graceful degradation. It does not give the exact shape of ownership data or the response envelope, but the coverage of outcomes is strong for the tool's complexity.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters4/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema description coverage is 100%, so baseline is 3; the description upgrades this by introducing ISIN as an accepted `value` form even though the schema only lists ticker, CIK, and name, and by explaining how ISINs map to legal entities via GLEIF. It also clarifies how the 'type' enum changes the meaning of `value`, adding semantics beyond the bare property descriptions.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description opens with concrete user utterances and a crisp verb phrase: 'resolve a user-spoken NAME to the canonical/official identifiers other tools require as input.' It further scopes the tool to two explicit entity types ('company', 'drug') and lists the identifiers each produces (CIK, LEI, FIGI, RxCUI), which clearly distinguishes it from sibling lookup/profile tools.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

It contains an explicit routing rule: 'Use FIRST whenever you have a name but need an ID.' It also explains that resolve_entity replaces 2-3 manual lookups, signalling when it is the efficient choice. It stops short of naming when-not-to-use alternatives (e.g., entity_profile) and so scores below 5.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

All Ted Eu toolsInspect
Try in Browser
RayrunBuild, deploy, and operate MCP servers without becoming an infrastructure team.ray.runAd

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A4.4/5.0
Disambiguation5/5

Each tool has a clearly distinct purpose described in detail. Even tools like ask_pipeworx, ask_pipeworx_grounded, and deep_research are differentiated by hallucination resistance, account requirements, and use cases. Polymarket tools are each specialized (arbitrage, edges, fill risk, etc.). No two tools appear to do the same thing.

Naming Consistency5/5

All tool names follow snake_case consistently. They use descriptive verb-noun patterns (e.g., ask_pipeworx, bet_research, compare_entities, subscribe). No mixing of conventions or ambiguous names.

Tool Count4/5

32 tools is on the higher side but justified by the server's broad scope covering company research, prediction markets, data lookups, memory, subscriptions, and more. Each tool serves a distinct function, though the count might feel slightly heavy for a single server.

Completeness4/5

The toolset covers core workflows for company analysis, prediction market operations, data retrieval, and system management (memory, subscriptions). Minor gaps exist (e.g., no direct tool for non-company entity profiles beyond drugs), but the overall surface is comprehensive for the intended multi-purpose assistant.

Resources